Proceedings of the Council for High Blood Pressure Research, 2002
This issue of Hypertension contains selected manuscripts based on presentations made at the 56th Annual Fall Conference and Scientific Sessions of the American Heart Association Council for High Blood Pressure Research. The meeting was held in Orlando, Florida, September 25 through 28, 2002. The conference was preceded by the Workshop on Inflammation and Oxidative Stress in the Cardiovascular System and Its Role in the Pathophysiology of Hypertension, Cardiovascular Disease, and Renal Disease, which was organized by Dr Ernesto Schiffrin. The program for the conference included 87 oral presentations and 253 posters that were selected from a record number 550 submitted abstracts. These presentations covered a variety of topics: from genetics, molecular biology, receptors, vascular biology, and signal transduction to clinical hypertension and obesity. Presenters were encouraged to submit manuscripts that would be considered for publication in this proceedings issue of Hypertension. Most of the manuscripts were reviewed by two referees and two members of the Publications Committee. There were 137 manuscripts submitted and 37 (27%) accepted for publication. This compares to the 127±5 manuscripts submitted and 72±4 (57±2%) accepted each year over the last 4 years. The marked reduction in this year’s acceptance rate was mandated by the American Heart Association and is in accordance with current American Heart Association policy for scientific journals. Thus, only the manuscripts that were highly meritorious and that required minor or no revisions were accepted. Unfortunately, these rigorous criteria eliminated several potentially outstanding manuscripts.
The transition to online submissions and reviews was initiated this year. Referee assignments and reviews were conducted electronically, and a complete evolution to online submission, processing, and reviewing of manuscripts should be in place for next year’s Supplement. Online submission has many advantages for authors and reviewers, and will be especially helpful for the Supplement by providing the best reviews in the limited time available to complete the review process. Members of the Publications Committee who contributed to the review process included Drs Abraham Aviv, Daniel Catanzaro, Anna Dominiczak, Irene Gavras, David Harder, Carmen Hinojosa-LaBorde, Osvaldo Kohlmann, Richard Roman, Addison Taylor, Stephanie Watts, and J Michael Wyss. In addition, ad hoc members to the Publications Committee were the editor-in-chief, Dr John Hall, and the associate editors of Hypertension, Drs Celso Gomez-Sanchez, Joey Granger, Daniel Jones, Friedrich Luft, and Curt Sigmund. Inclusion of these ad hoc members was especially valuable this year in expediting the online review process and maintaining the same high standards held for regular submissions to Hypertension.
I am grateful to all the Publications Committee members for the time and diligent efforts that they devoted to the evaluation of the submitted abstracts. I would also like to acknowledge all those who contributed to the conscientious and timely reviews of the manuscripts. Indeed, the quality of the Supplement is a reflection of their work. Their names are listed below. Finally, this Supplement would not have been possible without the dedicated support of the editorial staff of Hypertension, Gerry McAlpin, managing editor, and Cindy Means, associate managing editor. Both Gerry and Cindy worked arduously for several weeks, before and after the meeting of the Council, uploading and processing abstracts, manuscripts, and manuscript reviews for the Supplement. Simply put, publication of the Supplement could not have happened without their dedicated efforts.
Several invited lectures and awards were presented at the meeting of the Council. Drs Gerald DiBona and John Hall received the Novartis Award for Hypertension Research; Dr Gordon Williams presented the Arthur C. Corcoran Memorial Lecture; Dr Suzanne Oparil received the Council for High Blood Pressure Research Lifetime Achievement Award; Dr Hector M. Dourron received the 18th Annual Aventis Pharma Hypertension Research Clinical Fellowship Program Award; and Dr Robin Davisson received the Harry Goldblatt Award in Cardiovascular Research.
We will continue to strive to make this issue of Hypertension a valuable and comprehensive forum that showcases the latest developments and advances in the field of hypertension research. To this end, changes have and will continue to be made in the publication of outstanding peer-reviewed research articles. We solicit and encourage your articles and your input into the review process.
THANKS TO REFEREES
Hugh De Wardener
Neils Henrik Rathlou
Gian Paulo Rossi
Ewoud Van Dijk